April 24, 2018 Acadia prices 8 silagra .3 million public offering Acadia Healthcare Business, Inc. today announced a public giving of 8,333,333 shares of its common stock, pursuant to a sign up statement filed with the Securities and Exchange Commission . Acadia shall grant the underwriters a choice to acquire an additional 1,249,999 shares to cover over-allotments, if any. All of the shares in the offering shall be sold by Acadia. Jefferies & Company, Inc. And Citigroup shall serve as joint book-working managers in the offering. Acacia subsidiary acquires privileges to prescription lens technology patent portfolio Acacia Research Company announced today a subsidiary has acquired rights to a patent portfolio for prescription zoom lens technology. Acacia is rapidly becoming the first choice in technology licensing and we continue steadily to grow our base of future revenues by adding brand-new patent portfolios, concluded Mr. Ryan.